Literature DB >> 1535757

Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.

C S Bockman1, W B Jeffries, W A Pettinger, P W Abel.   

Abstract

The affinity of vascular vasopressin receptors was studied to determine its role in altered vascular contractile sensitivity in deoxycorticosterone acetate (DOCA)-salt hypertension. Ring segments of rat mesenteric arteries were used to study vascular vasopressin receptors. Male Wistar rats were given subcutaneous injections of DOCA and 1% NaCl in the drinking water. Mesenteric arteries from hypertensive rats had a reduced contractile sensitivity to arginine vasopressin (AVP) and lysine vasopressin (LVP). The order of potency of vasopressin receptor agonists (AVP greater than LVP greater than oxytocin) was the same in arteries from hypertensive compared with normotensive animals. The affinity of the vasopressin receptor antagonist [deamino-Pen1,O-Me-Tyr2,Arg8] vasopressin, and the affinities of the vasopressin receptor agonists AVP and LVP were not altered during developing DOCA-salt hypertension. There was no change in contractile sensitivity to norepinephrine and KCl in arteries from hypertensive rats. The reduced vasopressin contractile sensitivity is not due to a change in vasopressin receptor affinity but may be a compensatory response to elevated blood pressure. These data suggest that increased vascular sensitivity does not contribute to elevated blood pressure during the developing stage of DOCA-salt hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535757     DOI: 10.1152/ajpheart.1992.262.6.H1752

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction.

Authors:  Anyue Yin; Akihiro Yamada; Wiro B Stam; Johan G C van Hasselt; Piet H van der Graaf
Journal:  Br J Pharmacol       Date:  2018-07-10       Impact factor: 8.739

2.  Role of Acetyl Salicylic Acid in Controlling the DOCA-Salt Induced Hypertension in Rats by Stimulating the Synthesis of r-Cortexin in the Kidney.

Authors:  Uttam Kumar Maji; Pradipta Jana; Mitali Chatterjee; Sanmay Karmakar; Arup Saha; Tamal Kanti Ghosh
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-01-06

3.  Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2012-04-20       Impact factor: 4.530

4.  Role of aspirin activated nitric oxide synthase in controlling DOCA-salt-induced hypertension in rats through the stimulation of renal r-cortexin in kidney cortex cells.

Authors:  Uttam Kumar Maji; Tamal Kanti Ghosh; Mitali Chatterjee; Suman Bhattacharya; Sarbashri Bank; Pradipta Jana
Journal:  Int J Health Sci (Qassim)       Date:  2022 Jul-Aug

5.  Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products.

Authors:  Meng-Chun Cheng; Tzu-Ming Pan
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.